Dr. John Purves is a life science consultant having recently retired from the European Medicines Agency where he worked for 14 years, first as Head of the Biotechnology and Biological Products Sector and most recently, as Head of the Sector for the quality of medicines. He was involved in many areas dealing with biological medicinal products, including biosimilar, influenza and advanced therapy products. Prior to joining the EMA, Dr. Purves was Manager of the Biotechnology and Biological Unit at the UK Medicines Control Agency, now the Medicines and Healthcare Products Regulatory Agency. At the UK agency, he was involved in the drafting of a number of European Union guidelines including those on the manufacture and control of recombinant-DNA products and products derived from human blood and plasma. Dr. Purves also oversaw efforts to minimise the risk of the transmission of spongiform encephalopathies to humans through medicinal products. Dr. Purves graduated in pharmacy from the Heriot Watt University in Edinburgh in 1968 and received his doctorate in pharmaceutical microbiology from the University of Strathclyde in 1973. Following university, he worked in research and development at Smith and Nephew Ltd in the UK.